Emergent hid COVID-19 vaccine problems from FDA, report finds 

Emergent BioSolutions, a government contractor hired to produce hundreds of millions of COVID-19 vaccine doses, hid evidence of quality control problems from the FDA six weeks before it issued an alert that 15 million doses had been contaminated, The New York Times reported May 10.

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive